Keith Ward
Keith Ward to Lead Little Rock’s InterveXion Therapeutics
InterveXion Therapeutics of Little Rock, a private clinical-stage biopharmaceutical company focused on developing immunotherapies for substance abuse disorders, announced Monday the appointment of Keith Ward, Ph.D., to president and CEO. read more >